International Day for Interventional Cardiology, 16 September 2025
The International Day for Interventional Cardiology is observed annually on 16 September. This day is dedicated to raising awareness about the field of interventional cardiology and its role in treating heart diseases through minimally invasive procedures. It highlights advancements and achievements in the field, emphasizing the importance of cardiovascular health and innovative medical interventions.
In recognition of this important day, we recommend the following related articles, Special Issues, and journals spanning multidisciplinary fields, including clinical medicine. We believe that promoting such research contributes to enhanced public awareness and a greater understanding of cardiovascular diseases and procedures, related complications, prevention and care.
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
“Cellular and Molecular Bases for the Application of Polyphenols in the Prevention and Treatment of Cardiovascular Disease”
by Carlo Caiati and Emilio Jirillo
Diseases 2025, 13(7), 221; https://doi.org/10.3390/diseases13070221
“Comparative Analysis of Cardiovascular Outcomes in Type 2 Diabetes Patients Engaging in Aerobic, Resistance, and Combined Training: A Systematic Review”
by Sayed Alireza Mousavi Zadeh, Giuseppe Caminiti, Maurizio Aracri, Massimo Pieri, Anna Paola Mitterhofer, Antonino De Lorenzo, Sergio Bernardini, Pasquale Farsetti, Maurizio Volterrani, Rosario Barone et al.
Diabetology 2025, 6(5), 38; https://doi.org/10.3390/diabetology6050038
“Medical Therapy Versus Percutaneous Coronary Intervention in Patients with Myocardial Bridging from a National Population-Based Cohort Study: The Use of Big Data Analytics”
by Chayakrit Krittanawong, Song Peng Ang, Fernando Alexis Padilla, Yusuf Kamran Qadeer, Zhen Wang, Nicola Gaibazzi, Samin K. Sharma, Carl J. Lavie, Hartzell V. Schaff and Ernst R. Schwarz
Cardiogenetics 2025, 15(2), 10; https://doi.org/10.3390/cardiogenetics15020010
“Computed Tomography Angiography Identified High-Risk Coronary Plaques: From Diagnosis to Prognosis and Future Management”
by Kyriakos Dimitriadis, Nikolaos Pyrpyris, Panagiotis Theofilis, Emmanouil Mantzouranis, Eirini Beneki, Panagiotis Kostakis, George Koutsopoulos, Konstantinos Aznaouridis, Konstantina Aggeli and Konstantinos Tsioufis
Diagnostics 2024, 14(15), 1671; https://doi.org/10.3390/diagnostics14151671
“Emerging Transcatheter Therapies for Valvular Heart Disease: Focus on Mitral and Tricuspid Valve Procedures”
by Nikolaos Ktenopoulos, Odysseas Katsaros, Anastasios Apostolos, Maria Drakopoulou, Grigorios Tsigkas, Constantinos Tsioufis, Periklis Davlouros, Konstantinos Toutouzas and Antonios Karanasos
Life 2024, 14(7), 842; https://doi.org/10.3390/life14070842
“Zero-Fluoroscopy Catheter Ablation of Right Appendage Focal Atrial Tachycardia in a Pregnant Woman”
by Federica Troisi, Noemi Valenti, Federico Quadrini, Nicola Vitulano, Antonio Di Monaco, Imma Romanazzi, Rosa Caruso, Rocco Orfino and Massimo Grimaldi
Clin. Pract. 2024, 14(3), 946-953; https://doi.org/10.3390/clinpract14030075
“In-Stent Restenosis Overview: From Intravascular Imaging to Optimal Percutaneous Coronary Intervention Management”
by Neda Shafiabadi Hassani, Lucas Carlini Ogliari, Pedro Rafael Vieira de Oliveira Salerno, Gabriel Tensol Rodrigues Pereira, Marcelo Harada Ribeiro and Luis Augusto Palma Dallan
Medicina 2024, 60(4), 549; https://doi.org/10.3390/medicina60040549
“The Application of Precision Medicine in Structural Heart Diseases: A Step towards the Future”
by Grigorios Chrysostomidis, Anastasios Apostolos, Amalia Papanikolaou, Konstantinos Konstantinou, Grigorios Tsigkas, Antigoni Koliopoulou and Themistokles Chamogeorgakis
J. Pers. Med. 2024, 14(4), 375; https://doi.org/10.3390/jpm14040375
“Different Mechanisms in Doxorubicin-Induced Cardiomyopathy: Impact of BRCA1 and BRCA2 Mutations”
by Hien C. Nguyen, Jefferson C. Frisbee and Krishna K. Singh
Hearts 2024, 5(1), 54-74; https://doi.org/10.3390/hearts5010005
“Translational Relevance of Advanced Age and Atherosclerosis in Preclinical Trials of Biotherapies for Peripheral Artery Disease”
by Keith A. Webster
Genes 2024, 15(1), 135; https://doi.org/10.3390/genes15010135
“A Refractory Electrical Storm after Acute Myocardial Infarction: The Role of Temporary Ventricular Overdrive Pacing as a Bridge to ICD Implantation”
by Mijo Meter and Josip Andelo Borovac
Pathophysiology 2024, 31(1), 44-51; https://doi.org/10.3390/pathophysiology31010004
“Transcatheter Aortic Valve Replacement: Current Status and Future Indications”
by Manish Vinayak, Pier Pasquale Leone, Richard Tanner, Vishal Dhulipala, Anton Camaj, Rakhee Rajendra Kumar Makhija, Amit Hooda, Annapoorna S. Kini, Samin K. Sharma and Sahil Khera
J. Clin. Med. 2024, 13(2), 373; https://doi.org/10.3390/jcm13020373
“Gender Disparities after Transcatheter Aortic Valve Replacement with Newer Generation Transcatheter Heart Valves: A Systematic Review and Meta-Analysis”
by Angkawipa Trongtorsak, Sittinun Thangjui, Pabitra Adhikari, Biraj Shrestha, Jakrin Kewcharoen, Leenhapong Navaravong, Somsupha Kanjanauthai, Steve Attanasio and Hammad A. Saudye
Med. Sci. 2023, 11(2), 33; https://doi.org/10.3390/medsci11020033
|
“Advances in the Diagnosis and Management of Cardiovascular Diseases” |
“Pediatric Cardiology Frontiers: Innovations in Diagnosis and Treatment” |
|
“Clinical Advances in Cardiovascular Interventions” |
“New Horizons in the Diagnosis, Prevention and Treatment of Peripheral Artery Disease in Diabetes” |
|
“HTAAD: Unraveling the Molecular and Clinical Complexity of Heritable Thoracic Aortic Disease” |
“Insights into the Management of Cardiovascular Disease Risk Factors” |
|
“Recent Advances in Interventional Cardiology” |
“Interventional Cardiology: Advances in Personalized Treatment and Management” |
 |
 |